Inventor · disambiguated record
Susanne Paukner
Also filed as: PAUKNER SUSANNE
4 granted patents·5 pending applications·14 citations·filing 2001–2023
62Inventor score
Files withNabriva Therapeutics GmbH5ARIVA MED GMBH1LUBITZ WERNER1NABRIVA THERAPEUTICS AG1NABRIVA THERAPEUTICS FORSCHUNG1
Top patents by PatentIndex Score
9 records- 0179US6951756B2Closure of bacterial ghostLUBITZ WERNER·Filed 2001·Granted Oct 4, 2005·14 cites·35 claims
- 0250US2024208989A1Novel 12-epi-mutilin compounds and uses thereofNabriva Therapeutics GmbH·Filed 2022·Application pending·0 cites
- 0347US2025134844A1Therapeutic use of pleuromutilinsNabriva Therapeutics GmbH·Filed 2023·Application pending·0 cites
- 0444US2023218558A1Novel therapeutic use of pleuromutilinsNabriva Therapeutics GmbH·Filed 2021·Application pending·0 cites
- 0542US2023174509A1Therapeutic use of pleuromutilinsNabriva Therapeutics GmbH·Filed 2021·Application pending·0 cites
- 0641US7816389B2Organic compoundsNABRIVA THERAPEUTICS FORSCHUNG·Filed 2007·Granted Oct 19, 2010·0 cites·13 claims
- 0741US2023174472A1Therapeutic use of pleuromutilinsNabriva Therapeutics GmbH·Filed 2021·Application pending·0 cites
- 0839US12371441B2Siderophore cephalosporin conjugates and uses thereofARIVA MED GMBH·Filed 2020·Granted Jul 29, 2025·0 cites·30 claims
- 0926US9701628B212-epi pleuromutilinsNABRIVA THERAPEUTICS AG·Filed 2015·Granted Jul 11, 2017·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →